CHROMADEX CORPORATION (NASDAQ:CDXC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
of Directors (the Board) of ChromaDex Corporation (the Company).
Mr. Rubin was also appointed to serve as a member of the
Nominating and Corporate Governance Committee of the Board (the
Nominating and Corporate Governance Committee).
compensation policy, Mr. Rubin is entitled to receive an initial
grant consisting of a nonstatutory stock option to purchase
40,000 shares of the Companys common stock (the Common Stock),
which shares will vest in a series of three equal annual
installments. Mr. Rubin will also be entitled to receive a
$30,000 annual cash retainer for service as director and a $5,000
annual cash retainer for service as member of the Nominating and
Corporate Governance Committee, and will be eligible to receive
additional equity compensation in the future. Mr. Rubin will
enter into the Companys standard form of indemnification
agreement. The Company is not aware of any transaction involving
Mr. Rubin requiring disclosure under Item 404(a) of Regulation
S-K.
Mr. Rubins appointment to the Board, a copy of which is attached
hereto as Exhibit 99.1.
|
Item9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release, dated March 28, 2017
|
|
About CHROMADEX CORPORATION (NASDAQ:CDXC)
Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks. CHROMADEX CORPORATION (NASDAQ:CDXC) Recent Trading Information
CHROMADEX CORPORATION (NASDAQ:CDXC) closed its last trading session up +0.10 at 2.69 with 179,937 shares trading hands.